All terms in GO

Label Id Description
positive regulation of corticotropin secretion GO_0051461 [Any process that activates or increases the frequency, rate or extent of the regulated release of corticotropin hormone from a cell.]
positive regulation of cortisol secretion GO_0051464 [Any process that activates or increases the frequency, rate or extent of the regulated release of cortisol from a cell.]
negative regulation of cortisol secretion GO_0051463 [Any process that stops, prevents, or reduces the frequency, rate or extent of the regulated release of cortisol from a cell.]
negative regulation of corticotropin secretion GO_0051460 [Any process that stops, prevents, or reduces the frequency, rate or extent of the regulated release of corticotropic hormone from a cell.]
vesicle fusion with vacuole GO_0051469 [The joining of the lipid bilayer membrane around a vesicle with the lipid bilayer membrane around the vacuole.]
positive regulation of corticotropin-releasing hormone secretion GO_0051466 [Any process that activates or increases the frequency, rate or extent of the regulated release of corticotropin-releasing hormone from a cell.]
regulation of corticotropin-releasing hormone secretion GO_0043397 [Any process that modulates the frequency, rate or extent of corticotropin-releasing hormone secretion.]
negative regulation of corticotropin-releasing hormone secretion GO_0051465 [Any process that stops, prevents, or reduces the frequency, rate or extent of the regulated release of corticotropin-releasing hormone from a cell.]
detection of glucocorticoid hormone stimulus GO_0051468 [The series of events by which a glucocorticoid hormone stimulus is received by a cell and converted into a molecular signal. Glucocorticoids are hormonal C21 corticosteroids synthesized from cholesterol with the ability to bind with the cortisol receptor and trigger similar effects. Glucocorticoids act primarily on carbohydrate and protein metabolism, and have anti-inflammatory effects.]
detection of steroid hormone stimulus GO_0051467 [The series of events by which a steroid hormone stimulus is received by a cell and converted into a molecular signal.]
corticotropin-releasing hormone receptor 2 binding GO_0051431 [Binding to a corticotropin-releasing hormone receptor type 2 (CRHR2). The CRHR2 has several splice variants that are located in sub-cortical areas of the brain and in the periphery.]
corticotropin-releasing hormone receptor 1 binding GO_0051430 [Binding to a corticotropin-releasing hormone receptor 1 (CRHR1). CRHR1 is the major subtype in the pituitary corticotroph, and mediates the stimulatory actions of corticotropin-releasing hormone on corticotropin hormone secretion. CRHR1 are also located in cortical areas of the brain, cerebellum and limbic system.]
obsolete positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition GO_0051437 [OBSOLETE. Any process that activates, maintains or increases the rate of ubiquitin ligase activity that contributes to the regulation of the mitotic cell cycle phase transition.]
obsolete negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle GO_0051436 [OBSOLETE. Any process that stops, prevents, or reduces the frequency, rate or extent of ubiquitin ligase activity that contributes to the mitotic cell cycle.]
obsolete regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle GO_0051439 [OBSOLETE. A cell cycle process that modulates the frequency, rate or extent of ubiquitin ligase activity that contributes to the mitotic cell cycle.]
BH2 domain binding GO_0051433 [Binding to a BH2 protein domain, present in Bcl-2 family members. Proteins that act as inhibitors of apoptosis harbour at least three BH domains: BH1, BH2 and BH3; the BH1 and BH2 domains are found in all death antagonists of the Bcl-2 family but only in one class of death agonists.]
BH1 domain binding GO_0051432 [Binding to a BH1 protein domain, present in Bcl-2 family members. Proteins that act as inhibitors of apoptosis harbour at least three BH domains: BH1, BH2 and BH3; the BH1 and BH2 domains are found in all death antagonists of the Bcl-2 family but only in one class of death agonists.]
BH4 domain binding GO_0051435 [Binding to a BH4 protein domain, present in Bcl-2 family members. All anti-apoptotic proteins contain BH1 and BH2 domains; some also contain an additional N-terminal BH4 domain, which is almost never seen in pro-apoptotic proteins. Loss of the BH4 domain can diminish or abrogate anti-apoptotic function or even impart outright death-promoting properties to the protein.]
BH3 domain binding GO_0051434 [Binding to a BH3 protein domain, present in Bcl-2 family members. The BH3 domain is a potent death domain and has an important role in protein-protein interactions and in cell death.]
obsolete regulation of ubiquitin-protein ligase activity involved in meiotic cell cycle GO_0051440 [OBSOLETE. A cell cycle process that modulates the frequency, rate or extent of ubiquitin ligase activity during the meiotic cell cycle.]